2026 Q1 -tulosraportti
6 päivää sitten
‧43 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 862 | NON | ENS | ||
| 138 | NON | NON | ||
| 416 | NON | NON | ||
| 50 | NON | NON | ||
| 417 | DDB | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 101 057 | 66 531 | +34 526 | 49 156 |
| Danske Bank A/S | 26 973 | 6 744 | +20 229 | 1 090 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 3 739 | 48 271 | −44 532 | 0 |
| Skandinaviska Enskilda Banken AB | 7 737 | 18 822 | −11 085 | 1 025 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 29.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·51 min sittenNow, data is coming soon. Which parameters are the most important and how high do the numbers need to be before they don't disappoint?
·5 t sittenI know it's impossible to predict, and several here write that it could go all the way up to 500 if everything goes perfectly with Curasight, but what would a realistic price be at the end of the year if everything still goes as planned🤗
·4 t sittenSo average gak is 8.90kr
·6 t sittenIt's probably a long weekend soon, regarding Curas? Exciting many days where there's no possibility to trade, but news can probably still drop....even though it's raining all weekend and it's not exactly shorts weather...😆
·6 t sittendo you have pexa also allani?
·10 t sittenMax 26 days until preliminary biodistribution and dosimetry data are published...insanely exciting! Inderes' latest analysis overview lists several investment reasons in Curasight: 1: The market for uTREAT (where Curasight does not yet have a partnership agreement) is estimated to be 25x larger than uTRACE. (FYI: Curasight has a 70mio usd uTRACE partnership agreement with Curium for prostate cancer alone....what could it potentially amount to when uTREAT is calculated...) 2: First patient data in January showed very promising signs with "high tumour uptake + retention of up to 24 hours". 3: Big Pharma focuses (and invests/acquires) in the RLT sector...and moves quickly...even on companies that only have limited data available. Will it be an acquisition or a partnership for Curasight? 4: There are four important readouts before the end of the year. Add to that an (expected) increased market attention/interest, adjusted price targets and precisely speculation in acquisitions (and at a minimum, partnerships). 5: As a first-in-class treatment, Curasight can get by with smaller (and cheaper) clinical trials. This potentially also means a treatment that comes to market faster... Still reading..? :) Then drop a comment, whether you are short or long in the company + what expectations you have for the rest of the year & possibly, how long you have followed the case.
·5 t sittenBeen in since 2019 Has for a 6-figure amount Has a lot of knowledge from professional stock people Will not sell even if it 5x doubles 😃
·10 t sittenIn and out – certified future degenerate daytrader 🚀 Was long in Curesight and followed it all the way down… because who doesn't love to see their portfolio bleed 🩸🤡 It then crawls back up to "almost break-even", and I think: "THIS IS IT, I've become rational!" Sells half. Sells the rest. Feels like Warren Buffett for approx. 7 minutes. …and then the panic starts 💀 What if it nukes up +200% without me?! What if I just sold the bottom at the peak of my own IQ?! Couldn't sleep, of course. So yes… I'm all in again. 🤡📈 May the investment god be gracious to me… or else we'll see each other behind the Føtex container to pick up food 🫡🍗
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
6 päivää sitten
‧43 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·51 min sittenNow, data is coming soon. Which parameters are the most important and how high do the numbers need to be before they don't disappoint?
- ·5 t sittenI know it's impossible to predict, and several here write that it could go all the way up to 500 if everything goes perfectly with Curasight, but what would a realistic price be at the end of the year if everything still goes as planned🤗·4 t sittenSo average gak is 8.90kr
- ·6 t sittenIt's probably a long weekend soon, regarding Curas? Exciting many days where there's no possibility to trade, but news can probably still drop....even though it's raining all weekend and it's not exactly shorts weather...😆·6 t sittendo you have pexa also allani?
- ·10 t sittenMax 26 days until preliminary biodistribution and dosimetry data are published...insanely exciting! Inderes' latest analysis overview lists several investment reasons in Curasight: 1: The market for uTREAT (where Curasight does not yet have a partnership agreement) is estimated to be 25x larger than uTRACE. (FYI: Curasight has a 70mio usd uTRACE partnership agreement with Curium for prostate cancer alone....what could it potentially amount to when uTREAT is calculated...) 2: First patient data in January showed very promising signs with "high tumour uptake + retention of up to 24 hours". 3: Big Pharma focuses (and invests/acquires) in the RLT sector...and moves quickly...even on companies that only have limited data available. Will it be an acquisition or a partnership for Curasight? 4: There are four important readouts before the end of the year. Add to that an (expected) increased market attention/interest, adjusted price targets and precisely speculation in acquisitions (and at a minimum, partnerships). 5: As a first-in-class treatment, Curasight can get by with smaller (and cheaper) clinical trials. This potentially also means a treatment that comes to market faster... Still reading..? :) Then drop a comment, whether you are short or long in the company + what expectations you have for the rest of the year & possibly, how long you have followed the case.·5 t sittenBeen in since 2019 Has for a 6-figure amount Has a lot of knowledge from professional stock people Will not sell even if it 5x doubles 😃
- ·10 t sittenIn and out – certified future degenerate daytrader 🚀 Was long in Curesight and followed it all the way down… because who doesn't love to see their portfolio bleed 🩸🤡 It then crawls back up to "almost break-even", and I think: "THIS IS IT, I've become rational!" Sells half. Sells the rest. Feels like Warren Buffett for approx. 7 minutes. …and then the panic starts 💀 What if it nukes up +200% without me?! What if I just sold the bottom at the peak of my own IQ?! Couldn't sleep, of course. So yes… I'm all in again. 🤡📈 May the investment god be gracious to me… or else we'll see each other behind the Føtex container to pick up food 🫡🍗
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 862 | NON | ENS | ||
| 138 | NON | NON | ||
| 416 | NON | NON | ||
| 50 | NON | NON | ||
| 417 | DDB | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 101 057 | 66 531 | +34 526 | 49 156 |
| Danske Bank A/S | 26 973 | 6 744 | +20 229 | 1 090 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 3 739 | 48 271 | −44 532 | 0 |
| Skandinaviska Enskilda Banken AB | 7 737 | 18 822 | −11 085 | 1 025 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 29.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 |
2026 Q1 -tulosraportti
6 päivää sitten
‧43 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 29.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·51 min sittenNow, data is coming soon. Which parameters are the most important and how high do the numbers need to be before they don't disappoint?
- ·5 t sittenI know it's impossible to predict, and several here write that it could go all the way up to 500 if everything goes perfectly with Curasight, but what would a realistic price be at the end of the year if everything still goes as planned🤗·4 t sittenSo average gak is 8.90kr
- ·6 t sittenIt's probably a long weekend soon, regarding Curas? Exciting many days where there's no possibility to trade, but news can probably still drop....even though it's raining all weekend and it's not exactly shorts weather...😆·6 t sittendo you have pexa also allani?
- ·10 t sittenMax 26 days until preliminary biodistribution and dosimetry data are published...insanely exciting! Inderes' latest analysis overview lists several investment reasons in Curasight: 1: The market for uTREAT (where Curasight does not yet have a partnership agreement) is estimated to be 25x larger than uTRACE. (FYI: Curasight has a 70mio usd uTRACE partnership agreement with Curium for prostate cancer alone....what could it potentially amount to when uTREAT is calculated...) 2: First patient data in January showed very promising signs with "high tumour uptake + retention of up to 24 hours". 3: Big Pharma focuses (and invests/acquires) in the RLT sector...and moves quickly...even on companies that only have limited data available. Will it be an acquisition or a partnership for Curasight? 4: There are four important readouts before the end of the year. Add to that an (expected) increased market attention/interest, adjusted price targets and precisely speculation in acquisitions (and at a minimum, partnerships). 5: As a first-in-class treatment, Curasight can get by with smaller (and cheaper) clinical trials. This potentially also means a treatment that comes to market faster... Still reading..? :) Then drop a comment, whether you are short or long in the company + what expectations you have for the rest of the year & possibly, how long you have followed the case.·5 t sittenBeen in since 2019 Has for a 6-figure amount Has a lot of knowledge from professional stock people Will not sell even if it 5x doubles 😃
- ·10 t sittenIn and out – certified future degenerate daytrader 🚀 Was long in Curesight and followed it all the way down… because who doesn't love to see their portfolio bleed 🩸🤡 It then crawls back up to "almost break-even", and I think: "THIS IS IT, I've become rational!" Sells half. Sells the rest. Feels like Warren Buffett for approx. 7 minutes. …and then the panic starts 💀 What if it nukes up +200% without me?! What if I just sold the bottom at the peak of my own IQ?! Couldn't sleep, of course. So yes… I'm all in again. 🤡📈 May the investment god be gracious to me… or else we'll see each other behind the Føtex container to pick up food 🫡🍗
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 862 | NON | ENS | ||
| 138 | NON | NON | ||
| 416 | NON | NON | ||
| 50 | NON | NON | ||
| 417 | DDB | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 101 057 | 66 531 | +34 526 | 49 156 |
| Danske Bank A/S | 26 973 | 6 744 | +20 229 | 1 090 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 3 739 | 48 271 | −44 532 | 0 |
| Skandinaviska Enskilda Banken AB | 7 737 | 18 822 | −11 085 | 1 025 |
| SSW Market Making GmbH | 4 644 | 6 167 | −1 523 | 0 |
| Carnegie Investment Bank AB | 65 | 0 | +65 | 0 |
| Svenska Handelsbanken AB | 100 | 0 | +100 | 0 |
| Avanza Bank AB | 4 600 | 2 380 | +2 220 | 0 |